ARCHIVES

In Brief: James Downing named CEO of St. Jude

This article is from The Cancer Letter archive.

Vol. 40 No. 26 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

HRT Doesn’t Raise Cancer Risk Following Oophorectomy

October 28, 2005

Study Finds No Link Between Tumor Grade and Relapse Risk

February 25, 2011

NCI-Approved Clinical Trials Listed For June 2001

July 27, 2001

Medline Plus Provides Info To Patients About Prescriptions

May 28, 2004

Conversation With The Cancer Letter: Wicha to Leave Director’s Job at UMich

November 8, 2013

In Brief; NCAB To Hear Report On Human Cancer Virus, Mayo Projects, Proposed FDA Regulations

February 28, 1975